One and done? new prostate cancer radiation trial aims to cut treatment to a single session
NCT ID NCT07407608
First seen Feb 13, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study tests whether a single, precise dose of radiation can safely control prostate cancer in men with intermediate or high-risk disease. About 58 participants will receive one targeted treatment session, along with standard hormone therapy. The goal is to see if this shorter approach causes fewer side effects than the usual 5-dose regimen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiation Oncology, Fondazione IRCCS San Gerardo dei Tintori
RECRUITINGMonza, MB, 20900, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.